Mark Yarchoan, M.D, is an Associate Professor of Medical Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore Maryland. Dr. Yarchoan has a clinical focus on the treatment of hepatobiliary cancers, and he runs an NCI-funded laboratory focused on developing novel immunotherapies for hepatobiliary cancers, with a focus on neoantigen-targeted vaccines.